|
|
|
|
Straightforward MDM
The table below is from the 2021 E/M guidelines, first released in 2021, with minor revisions added in 2023.
|
MDM |
Number and complexity of problems addressed |
Amount and/or complexity of data reviewed |
Risk of complications and/or morbidity |
SF |
- One self-limited or minor problem
|
|
- Minimal risk or morbidity from additional diagnostic testing or treatment
|
Requires 2 out of 3 dimensions to qualify. |
|
|
|
|
|
|
|
|
|
|
|
|
|